from the artificial-assemblies dept.
Mr_Farlops writes "Business Week highlights the work of chemist George Whitesides and his startup, Surface Logix which plans to build cell-based sensors to help quickly screen new drugs and to build polyvalent drugs that, unlike most conventional drugs, bind to multiple sites on specfic proteins involved in disease. Whitesides hopes to fuse biotech and chemistry to develop novel methods of self-assembly as well."
